par AlzChem Group AG (isin : DE000A0AHT46)
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 2nd Interim Report
EQS-News: Alzchem Group AG / Key word(s): Share Buyback
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 2nd Interim Report
16.12.2024 / 12:05 CET/CEST
The issuer is solely responsible for the content of this announcement.
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, December 16th, 2024
2nd Interim Report
In the period from December 9th up to and including December 13th, 2024, a total of 13.964 shares of Alzchem Group AG were acquired as part of the share buyback programme announced on November 5th, 2024. The total number of shares acquired to date as part of this buyback amounts to 16.301. The acquisition was carried out by a financial institution via the stock exchange (XETRA) on behalf of Alzchem Group AG.
The total number of repurchased shares, the weighted average price and the aggregated volume (excl. acquisition costs) per day were as follows:
This information as well as the detailed information on the individual daily transactions related to the buy-back programme are also published on the Company's website at https://www.alzchem.com/en/investor-relations/stock/#c18518 in accordance with Art. 2 par. 3 sentence 2 of Delegated Regulation (EU) 2016/1052.
Alzchem Group AG
- Managing Board -
16.12.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: | English |
Company: | Alzchem Group AG |
Dr.-Albert-Frank-Str. 32 | |
83308 Trostberg | |
Germany | |
Phone: | +498621862888 |
Fax: | +49862186502888 |
E-mail: | ir@alzchem.com |
Internet: | www.alzchem.com |
ISIN: | DE000A2YNT30 |
WKN: | A2YNT3 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
EQS News ID: | 2052041 |
End of News | EQS News Service |
2052041 16.12.2024 CET/CEST